D. Hartl (Tuebingen, Germany), C. Kaehler (Innsbruck, Austria), C. Gunaratnam (Dublin, Ireland)
Discovery of candidate proteins, PIGR and SELENBP1, as novel markers of airway diseases in COPD
H. Nakamura, M. Nakamura, S. Chubachi, T. Nakajima, T. Shirahata, S. Takahashi, N. Minematsu, H. Tateno, C. Murata, H. Tada, K. Asano, T. Betsuyaku (Tokyo, Moroyama-machi, Tsukuba, Isehara, Japan)
|  |
Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS)
S. S. Sohal, S. D. Shukla, D. Reid, E. H. Walters, J. Grigg (London, United Kingdom; Hobart, Brisbane, Australia)
| |
Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure
M. I. Vargas-Rojas, H. Solleiro-Villavicencio, A. Ramírez-Venegas, M. Velázquez-Uncal, R. Quintana, R. Sansores-Martínez (Mexico, Mexico)
|  |
IL32 expression in induced sputum of COPD subjects
M. C. Scarpa, K. Lokar Oliani, F. Liviero, S. Baraldo, G. Turato, F. Calabrese, M. Saetta, P. Maestrelli (Padova, Italy)
| |
Surfactant protein D and its oligomeric forms in chronic obstructive pulmonary disease
S. Lyamina, S. Kalish, I. Malyshev (Moscow, Russian Federation)
| |
Association between qPCR bacterial load and airway inflammation in COPD
N. Rana, B. Barker, K. Haldar, H. Patel, V. Mistry, M. Pancholi, M. Barer, C. Brightling, M. Bafadhel (Leicester, United Kingdom)
| |
Similar adaptive immune response in COPD patients with and without alpha1 antitrypsin deficiency
S. Baraldo, E. Bazzan, G. Turato, B. Molena, F. Lunardi, N. Nannini, M. Damin, M. Schiavon, E. Balestro, M. Loy, F. Rea, M. Cosio, F. Calabrese, M. Saetta (Padova, Italy; Monetreal, Canada)
| |
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
A. Delieva, L. Dolinina, V. Trofimov (St. Petersburg, Russian Federation)
| |
Changes of IL-6 level in bronchoalveolar fluid in patients with acute exacerbation of COPD before and after the treatment with tiotropium bromide, and its significance
M. Kulynych-Miskiv, M. Ostrovskyy, O. Varunkiv, I. Savelikhina (Ivano-Frankivsk, Ukraine)
| |
Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease
C. H. Wang, T. T. Huang, H. P. Kuo (Taipei, Taiwan)
| |
Pulmonary and systemic inflammation in patients with AECOPD
S. Liu, Y. Shen, Q. Li, C. Wang (Chongqing, China)
| |
Adenovirus-specific immunoglobulin G maturation in acute exacerbations of COPD
L. Boeck, M. Gencay, M. Roth, H. Hirsch, M. Christ-Crain, B. Müller, M. Tamm, D. Stolz (Basel, Aarau, Switzerland)
| |
Blood T regulatory lymphocytes number is decreased in severe COPD
V. Sileikiene, E. Danila, L. Jurgauskiene (Vilnius, Lithuania)
| |
Neutrophil numbers are decreased in bronchial biopsies from patients with COPD
S. S. Sohal, D. Tan, H. K. Muller, D. Reid, E. H. Walters (Hobart, Brisbane, Australia)
| |
Evaluation of IL-8 and MEF25-75 in patients with severe COPD who were treated with combined therapy of ICSs / LABAs plus tiotropium bromide
E. Janeva, Z. Goseva, A. Gjorcev, S. Arbutina, M. Zdraveska, D. Dimitrievska, D. Todevski, D. Trajkov (Skopje, Fyrom)
| |
Expression of HLA-DR in circulating polymorphonuclear neutrophils of COPD patients
S. Scrimini, J. Pons, B. Cosío, A. Agusti, A. Jahn, R. Córdova, J. Sauleda (Palma de Mallorca, Barcelona, Spain)
| |
Myofibroblast expression in airways and alveoli is affected by smoking and COPD
H. Karvonen, S. Lehtonen, T. Harju, R. Sormunen, E. Lappi-Blanco, J. Mäkinen, K. Laitakari, S. Johnson, R. Kaarteenaho (Oulu, Kuopio, Finland)
| |
Women are more sensitive to tobacco smoke - Some insights to immune system
R. Chadzynski, G. Hoser, J. Domagala-Kulawik (Warsaw, Poland)
| |
Targeting PI3KΔ or JAK in T-cells from COPD and severe asthma subjects reduces corticosteroid insensitive inflammatory responses
T. Southworth, J. Plumb, V. Gupta, I. Ramis, M. D. Lehner, D. Singh (Manchester, United Kingdom; Barcelona, Spain)
| |
Increased circulating endothelial microparticles in COPD
J. García, R. Del Pozo, N. Coll, C. Bonjoch, I. Crespo, M. Musri, O. Tura, V. I. Peinado, J. A. Barberà (Barcelona, Spain)
| |